By Daniel R. Matlis It’s a trick question. Technically both should be sterile. But you would think that cardioplegia, the solution used to stop the …
What’s More Sterile: the Band-Aid on Your Paper cut or Cardioplegia? Read More »
On August 3, 2006 MRO Software announced that it has agreed to be acquired by IBM. So, what the impact on Life-Sciences Customers? I think …
The impact of IBM’s Acquisition of MRO Software on the Life-Sciences Market Read More »
I recently read an article on the Free Software Foundation’s Website entitled “Regulatory compliance is no reason to lock up users” The author states that …
This week, Scott Gottlieb, MD Deputy Commissioner for Medical and Scientific Affairs at the Food and Drug Administration made an interesting speech before the 2006 …
Doctors Don’t Treat Populations, They Treat Individual Patients Read More »
During my senior year, I was lucky to have a few job offers to evaluate. The top two were from Johnson & Johnson and Exxon. …
"Medicine is for the People, not for the Profits." Read More »
By Daniel R. Matlis It’s 3:00 AM and your newborn baby wakes up crying. You want to go back to sleep, but his circadian rhythm …
By Daniel R. Matlis Johnson & Johnson already had the title of the world’s most comprehensive and broadly based manufacturer of health care products, but …
Johnson & Johnson to Acquire Pfizer Consumer Healthcare Read More »
By Daniel R. Matlis According to the Food, Drug, and Cosmetic Act, FDA statutorily required to inspect domestic drug manufacturing establishments at least once every …
By Daniel R. Matlis In the past few years, CDER has made significant changes to advance and facilitate the review of electronic regulatory submissions. These …
Efficiency, Effectiveness and FDA All In The Same Sentence? Read More »
By Daniel R. Matlis “This is a Challenging time for the FDA and the Industry” said Janet Woodcock, MD, FDA’s Deputy Commissioner of Operations and …
FDA Must Become An Information Provider As Well As A Regulator Read More »
By Daniel R. Matlis The American Medical Association’s new policy on Direct to Consumer Advertising includes imposing a temporary moratorium on newly approved drugs and …
AMA Calls For Moratorium On Advertising Of Prescription Drugs And Devices Read More »
By Daniel R. Matlis In his recent InformationWeek article entitled “Let The UBS Trial Be A Warning To You” Mitch Wagner covers the trial against …
